Dilyara Radikovna Kaidarova (1), Mikhail Valeryevich Kopp (2), Vadim S Pokrovsky (3), Maia Dzhugashvili (4) , Zhanna Mukhataevna Akimzhanova (5), Ramil Zufarovich Abdrakhmanov (1), Elena Nikolaevna Babich (6), Evgeniy Viktorovich Bilan (6), Anton Valeryevich Byakhov (7), Sergey Nikolaevich Gurov (8),Irina Albertovna Koroleva (2), Anastasiia Sergeevna Mochalova (9), Svetlana Sergeevna Povaga (10) , Maxim Vladimirovich Raigorodsky (11), Arthur Sidorovich Saifullin (12), Eduardo Sanz (13), Fedor Igorevich Petrovskiy (14). 1 Kazakh Research Institute of Oncology and Radiology, Almaty 050000, Republic of Kazakhstan; 2 Department of Clinical Medicine, Medical University ‘Reaviz’, Samara 443001; 3 Department of Biochemistry
N.N. Blokhin Cancer Research Center, RUDN University, Moscow 115478, Russia; 4 Department of Oncology Radiology Murcia University, Murcia 30200, Spain; 5 Department of Chemotherapy, Almaty Oncology Center, Almaty 050060, Republic of Kazakhstan; 6 Department of Oncology, Khanty‑Mansiysk Regional Clinical Hospital, Khanty‑Mansiysk 628012; 7 Department of Chemotherapy, Moscow Clinical Scientific Center n. a. A.S. Loginov; Moscow 111123;
8 Department of Chemotherapy, Moscow Oncologic Clinical Dispensary No. 1, Moscow 105005; 9 Department of Chemotherapy, Clinical Hospital No. 1 MEDSI, Moscow 143442; 10 Department of Chemotherapy Russian Railways Hospital at The Station Smolensk, Smolensk 214025; 11 Department of Oncology, Medical Center ‘EVIMED’ LLC, Chelyabinsk 454048; 12 Department of Chemotherapy, Surgut Regional Hospital, 13 Surgut 628400, Russia;
Scientific Department, Catalysis S.L., Madrid 28016, Spain; 14 Department of Pharmacology and Clinical Pharmacology, Khanty‑Mansiysk State Medical Academy, Khanty‑Mansiysk 628011, Russia. ONCOLOGY LETTERS 18: 5644-5652, 2019
Размер файла: 1280.19 Кб |
Скачиваний:
3
|
Загрузить